Q4 2025 Earnings Call January 20, 2026 10:00 AM ESTCompany ParticipantsMatt Curoe - Senior Director of Investor ...
Real-time ¹⁹F NMR enables faster, more efficient pharmaceutical synthesis by improving reaction monitoring, scalability, and ...
This up-date of a Cochrane Review evaluated the benefits and harms of SMT compared to (1) sham SMT/placebo intervention, (2) no treatment, and (3) other conservative interventions in people with ...
The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback